Email this page...
From:
Email:
To:
Email:
Message:
send me a copy of the e-mail
Email Off -->
Navigation Speaker Information
Derek Cole, ARCA Biopharma, Inc. Derek Cole
ARCA Biopharma, Inc.
Chair, NIRI National
Board of Directors
General Session Speaker
Derek Cole
Vice President, Investor Relations & Corporate Communications
ARCA Biopharma, Inc.
 
Biography
Derek Cole is vice president, investor relations and corporate communications for ARCA biopharma Inc., Bloomfield, CO.

Cole has been involved in the capital markets and strategic planning for over 17 years with 12 years of dedicated investor relations experience focused on supporting the development of small- and mid-cap companies. He has managed or contributed to a broad spectrum of financing transactions, raising approximately $800 million, as well as supporting four M&A transactions. Cole was recently with Allos Therapeutics, Inc. as their vice president, investor Relations. Prior to Allos, Cole headed the investor relations and corporate communications function at Myogen, Inc., from its days as a private company, through its Initial Public Offering and continuing until its recent $2.5 billion acquisition. He is an active member of the National Investor Relations Institute (NIRI) currently serving as President of the Rocky Mountain Chapter and as a member of the BioPharma Roundtable steering committee. Cole is also on the Board of Directors of the Colorado BioScience Association (CBSA).


 *subject to change

 

Contact Tammy Dang (tdang@niri.org) with session inquiries.